ATE495258T1 - Bacteriocine - Google Patents

Bacteriocine

Info

Publication number
ATE495258T1
ATE495258T1 AT96911097T AT96911097T ATE495258T1 AT E495258 T1 ATE495258 T1 AT E495258T1 AT 96911097 T AT96911097 T AT 96911097T AT 96911097 T AT96911097 T AT 96911097T AT E495258 T1 ATE495258 T1 AT E495258T1
Authority
AT
Austria
Prior art keywords
nisin
bacteriocin
inhibiting
properties
novel
Prior art date
Application number
AT96911097T
Other languages
English (en)
Inventor
Maire Ryan
Reynolds Ross
Mary Rea
Colin Hill
Original Assignee
Teagasc Agric Food Dev Authori
Univ College Cork Nat Univ Ie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teagasc Agric Food Dev Authori, Univ College Cork Nat Univ Ie filed Critical Teagasc Agric Food Dev Authori
Application granted granted Critical
Publication of ATE495258T1 publication Critical patent/ATE495258T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B11/00—Preservation of milk or dairy products
    • A23B11/60—Preservation of cheese or cheese preparations
    • A23B11/65—Preservation of cheese or cheese preparations by addition of preservatives
    • A23B11/67—Preservation of cheese or cheese preparations by addition of preservatives of antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00—Preservation of foods or foodstuffs, in general
    • A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
    • A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
    • A23B2/729—Organic compounds; Microorganisms; Enzymes
    • A23B2/7295—Antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/02—Making cheese curd
    • A23C19/032—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin
    • A23C19/0323—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin using only lactic acid bacteria, e.g. Pediococcus and Leuconostoc species; Bifidobacteria; Microbial starters in general
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Dairy Products (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
AT96911097T 1995-04-12 1996-04-12 Bacteriocine ATE495258T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IE950269 IES70514B2 (en) 1995-04-12 1995-04-12 Bacteriocins
PCT/IE1996/000022 WO1996032482A1 (en) 1995-04-12 1996-04-12 Bacteriocins

Publications (1)

Publication Number Publication Date
ATE495258T1 true ATE495258T1 (de) 2011-01-15

Family

ID=11040718

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96911097T ATE495258T1 (de) 1995-04-12 1996-04-12 Bacteriocine

Country Status (9)

Country Link
US (1) US6207411B1 (de)
EP (1) EP0821736B1 (de)
JP (1) JP4360693B2 (de)
AT (1) ATE495258T1 (de)
AU (1) AU712143B2 (de)
DE (1) DE69638319D1 (de)
IE (1) IES70514B2 (de)
NZ (1) NZ305941A (de)
WO (1) WO1996032482A1 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221847B1 (en) 1996-09-13 2001-04-24 Clemson University Composition and method for treating bacterial infection
ATE281150T1 (de) * 1996-09-13 2004-11-15 Univ Clemson Mittel zur akne behandlung
PT1090035E (pt) * 1998-06-22 2008-05-12 Agric And Food Develop Authori Bacteriocina em pó seca por pulverização com actividade antimicrobiana
WO1999066949A2 (en) * 1998-06-22 1999-12-29 Teagasc, The Agriculture And Food Development Authority An antimicrobial effective against gram-positive pathogens
AU6027300A (en) 1999-07-06 2001-01-22 Friesland Brands B.V. Methods and means for producing improved dairy products
US6451365B1 (en) 2000-07-14 2002-09-17 Rhodia Inc. Antibacterial composition for control of gram positive bacteria in food applications
US20070003508A1 (en) 2005-07-01 2007-01-04 Wooley Richard E Methods and compositions for promoting wound healing
US20040208842A1 (en) * 2001-09-18 2004-10-21 Ritchie Branson W. Antimicrobial cleansing compositions and methods of use
US20040151765A1 (en) * 2001-09-18 2004-08-05 Ritchie Branson W. Methods and compositions for wound management
ES2170723B1 (es) * 2001-01-15 2003-12-16 Consejo Superior Investigacion Lactococcus lactis productor de bacteriocina utilizable como cultivo iniciador para acelerar la maduracion de queso.
AU2002358522A1 (en) 2001-11-29 2003-06-10 Vrije Universiteit Brussel A food grade lantibiotic from streptococcus macedonicus and uses thereof
US6861236B2 (en) * 2002-05-24 2005-03-01 Applied Nanosystems B.V. Export and modification of (poly)peptides in the lantibiotic way
CA2404356A1 (en) * 2002-09-18 2004-03-18 Canadian Inovatech Inc. Gram-positive antibacterial composition and method for use
WO2004068967A1 (en) 2003-02-03 2004-08-19 General Mills, Inc. Dough compositions comprising encapsulated organic acid and natural antimicrobial agent
US7112323B2 (en) * 2003-05-07 2006-09-26 Kraft Foods Holdings, Inc. Intracellular proteinacious antimicrobial agents from lactic acid bacteria derived from fermented food samples
IE20030773A1 (en) * 2003-10-17 2005-04-20 Teagasc Agric Food Dev Authori Use of probiotic bacteria in the treatment of infection
EP1706126A4 (de) * 2003-12-04 2009-07-01 Biofilms Strategies Inc Verfahren und zusammensetzungen zur verhinderung der ausbildung von biofilmen, reduzierung bestehender biofilme, und zur reduzierung bestehender biofilme und zur reduzierung von bakterienpopulationen
AU2005207684B2 (en) 2004-02-02 2009-12-17 Zoetis Broomhill Ip Limited Method and device for treating a teat canal of an animal
CA2944753A1 (en) 2004-02-02 2005-08-11 Bimeda Research & Development Limited Sequential delivery injector device
US20070185202A1 (en) * 2004-03-03 2007-08-09 University Of Georgia Research Foundation, Inc. Methods and compositions for ophthalmic treatment of fungal and bacterial infections
US7247306B2 (en) * 2004-04-30 2007-07-24 Universite Laval Bacteria strain and bacteriocin produced therefrom
CA2566617C (en) * 2004-05-14 2013-12-31 Agtech Products, Inc. Method and composition for reducing e.coli disease and enhancing performance using bacillus
US20060153811A1 (en) * 2005-01-10 2006-07-13 Jackson Lee E Use of viruses and virus-resistant microorganisms for controlling microorganism populations
CN100368016C (zh) * 2005-04-01 2008-02-13 北京大北农农业科技研究院 治疗奶牛乳房炎的乳房灌注液及其制备方法
CN1306025C (zh) * 2005-05-26 2007-03-21 沈颜新 一种培养基、其制备方法及培养乳酸链球菌素的方法
JP4789540B2 (ja) * 2005-08-08 2011-10-12 埼玉県 大腸菌群の汚染源特定方法及びその検出に使用する大腸菌群検出用培地セット
US7754469B2 (en) * 2005-11-30 2010-07-13 Agtech Products, Inc Microorganisms and methods for treating poultry
WO2007106951A1 (en) 2006-03-23 2007-09-27 Agriculture Victoria Services Pty Limited Antimicrobial protein
NL1032678C2 (nl) * 2006-10-13 2008-04-15 Friesland Brands Bv Werkwijze voor het bereiden van een half-harde of harde kaas en aldus verkregen kaas.
US20080152758A1 (en) * 2006-12-22 2008-06-26 Zuoxing Zheng Refrigerated Dough with Enhanced Microbiological Safety
US20090104157A1 (en) * 2007-10-05 2009-04-23 E. I. Du Pont De Nemours And Company Utilization of bacteriophage to control bacterial contamination in fermentation processes
WO2009059054A2 (en) * 2007-10-30 2009-05-07 The Trustees Of The University Of Pennsylvania Bacteria strains an d bacteriocin produced therefrom
NZ588018A (en) * 2008-03-13 2012-11-30 Agriculture Victoria Serv Pty Method of treatment using antimicrobial composition
US8021654B2 (en) 2008-03-14 2011-09-20 Danisco A/S Methods of treating pigs with Bacillus strains
CA2658440C (en) 2008-04-04 2016-08-23 Kraft Foods Global Brands Llc Dairy composition with probiotics and anti-microbial system
US8025874B2 (en) * 2008-04-17 2011-09-27 Danisco A/S Bacillus strains useful for animal odor control
US8540981B1 (en) 2008-07-07 2013-09-24 Dupont Nutrition Biosciences Aps Bacillus strains useful against calf pathogens and scours
JP2012034616A (ja) * 2010-08-06 2012-02-23 Umeya Co Ltd 塩たらこの製造方法及び塩たらこ、並びに辛子明太子の製造方法及び辛子明太子
WO2012109121A1 (en) * 2011-02-07 2012-08-16 Purdue Research Foundation Carbohydrate nanoparticles for prolonged efficacy of antimicrobial peptide
US8557234B1 (en) 2011-05-18 2013-10-15 Dupont Nutrition Biosciences Aps Methods of controlling pit foam
CN103930540B (zh) 2011-08-24 2017-05-17 杜邦营养生物科学有限公司 产酶芽孢杆菌菌株
US11206838B2 (en) 2013-04-11 2021-12-28 General Mills, Inc. Batter compositions, packaged batter products, and related methods
EA035622B1 (ru) 2014-12-19 2020-07-16 СиЭсКей ФУД ЭНРИЧМЕНТ Б.В. Способ производства сыра типа швейцарского
DK3053446T3 (da) 2014-12-19 2019-05-27 Csk Food Enrichment Bv Fremgangsmåde til fremstilling af schweizerost
US9883689B2 (en) * 2015-04-17 2018-02-06 Kerry Luxembourg S.à.r.l. Composition and methods to control the outgrowth of pathogens and spoilage microorganisms in high moisture and low sodium systems
US10327463B2 (en) 2015-04-17 2019-06-25 Kerry Luxembourg S.à.r.l. Composition and methods to control the outgrowth of pathogens and spoilage microorganisms in high moisture and low sodium systems
US11304888B2 (en) 2019-04-29 2022-04-19 Sunstar Americas, Inc. Oral care composition
JP2023068430A (ja) * 2021-11-02 2023-05-17 住友化学株式会社 抗菌ペプチド

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5348881A (en) * 1990-03-13 1994-09-20 Quest International Flavors & Good Ingredients Company, Division Of Indopco, Inc. Multiple bacteriocin producing lactococcus and compositions
DE4215494A1 (de) 1992-05-12 1993-11-25 Basf Ag Verfahren zur Herstellung von Hydroxypivalinsäureestern

Also Published As

Publication number Publication date
EP0821736B1 (de) 2011-01-12
US6207411B1 (en) 2001-03-27
AU712143B2 (en) 1999-10-28
AU5408196A (en) 1996-10-30
JPH11511648A (ja) 1999-10-12
IES950269A2 (en) 1996-10-16
IES70514B2 (en) 1996-12-11
JP4360693B2 (ja) 2009-11-11
NZ305941A (en) 1999-01-28
WO1996032482A1 (en) 1996-10-17
DE69638319D1 (de) 2011-02-24
EP0821736A1 (de) 1998-02-04

Similar Documents

Publication Publication Date Title
DE69638319D1 (de) Bacteriocine
Naclerio et al. Antimicrobial activity of a newly identified bacteriocin of Bacillus cereus
Blankenvoorde et al. Inhibition of the Growth and Cysteine Proteinase Activity ofPorphyromonas gingivalisby Human Salivary Cystatin S and Chicken Cystatin
EP1160327A3 (de) Proteolytische Enzyme und ihre Verwendung in Waschmitteln
Potempa et al. Porphyromonas gingivalis proteinases in periodontitis, a review.
ATE315639T1 (de) Alkalische xyloglukanase
ATE124718T1 (de) Neuartige proteasen.
Ikeda et al. Purification and certain properties of a bacteriocin from Streptococcus mutans
BR9914066A (pt) Polipeptìdio degradador de c3 de complemento humano de streptococcus pneumoniae
Mäkinen et al. An endo-acting proline-specific oligopeptidase from Treponema denticola ATCC 35405: evidence of hydrolysis of human bioactive peptides
Fricke et al. The cell envelope-bound metalloprotease (camelysin) from Bacillus cereus is a possible pathogenic factor
Sojar et al. Structures involved in the interaction of Porphyromonas gingivalis fimbriae and human lactoferrin
DE60228878D1 (de) Proteine mit il-6 inhibitorischer wirkung
FI952080A0 (fi) Bakteriosiinit Streptococcus thermophilus'ista
ES2153433T3 (es) Inhibidores de trombina bivalentes.
Goldstein et al. Novel extracellular x-prolyl dipeptidyl-peptidase (DPP) from Streptococcus gordonii FSS2: an emerging subfamily of viridans streptococcal x-prolyl DPPs
EP0852502A4 (de) Lantibiotikmutanten und chimeren mit erhöhter stabilität und aktivität
GB2365771B (en) Pepsin inhibition by alginates
ES2018734A6 (es) Procedimiento para la obtencion de un enzima proteolitico.
WO2002034918A3 (en) E. coli 0157:h7 c1 esterase inhibitor-binding protein stce and uses thereof
Takano et al. The reactive site of marinostatin, a proteinase inhibitor from marine Alteromonas sp. B-10-31
ATE326528T1 (de) Alkalische xyloglukanase aus malbranchea
EP1335743A4 (de) Hemmung oder umkehrung der hautalterung durch actin-sequestering peptide
Kato et al. Antibacterial substances produced by Enterococcus faecium
Ooi et al. Structural and functional organization of the human neutrophil 60 kDa bactericidal/permeability-increasing protein

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties